NanoCor (NAN-CS101)

NanoCor (NAN-CS101)

This is a Phase 1 study to explore the safety, feasibility, and efficacy of a single intracoronary infusion of BNP116.sc-CMV.I1c in patients with NYHA Class III heart failure. 

Please use this link for further information:

Primary Investigator: Tim Henry

Enrolling

Disclaimer: Patients must have an existing, documented diagnosis to be entered into some trials.
Copyright © 2024 All rights reserved.

Web Design by TBH Creative